AMSSM position statement on cardiovascular preparticipation screening in athletes: Current evidence, knowledge gaps, recommendations and future directions

Jonathan A. Drezner, Francis G. O'Connor, Kimberly G. Harmon, Karl B. Fields, Chad A. Asplund, Irfan M. Asif, David E. Price, Robert J. Dimeff, David T. Bernhardt, William O. Roberts

Research output: Contribution to journalArticle

  • 11 Citations

Abstract

Cardiovascular screening in young athletes is widely recommended and routinely performed prior to participation in competitive sports. While there is general agreement that early detection of cardiac conditions at risk for sudden cardiac arrest and death (SCA/D) is an important objective, the optimal strategy for cardiovascular screening in athletes remains an issue of considerable debate. At the centre of the controversy is the addition of a resting ECG to the standard preparticipation evaluation using history and physical examination. The American Medical Society for Sports Medicine (AMSSM) formed a task force to address the current evidence and knowledge gaps regarding preparticipation cardiovascular screening in athletes from the perspective of a primary care sports medicine physician. The absence of definitive outcome-based evidence at this time precludes AMSSM from endorsing any single or universal cardiovascular screening strategy for all athletes, including legislative mandates. This statement presents a new paradigm to assist the individual physician in assessing the most appropriate cardiovascular screening strategy unique to their athlete population, community needs and resources. The decision to implement a cardiovascular screening programme, with or without the addition of ECG, necessitates careful consideration of the risk of SCA/D in the targeted population and the availability of cardiology resources and infrastructure. Importantly, it is the individual physician's assessment in the context of an emerging evidence base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm. AMSSM is committed to advancing evidenced-based research and educational initiatives that will validate and promote the most efficacious strategies to foster safe sport participation and reduce SCA/D in athletes.

LanguageEnglish (US)
Pages153-167
Number of pages15
JournalBritish Journal of Sports Medicine
Volume51
Issue number3
DOIs
StatePublished - Feb 1 2017

Fingerprint

Sports Medicine
Medical Societies
Sudden Cardiac Death
Athletes
Physicians
Sports
Electrocardiography
Population
Advisory Committees
Cardiology
Physical Examination
Direction compound
Primary Health Care
History
Research

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

AMSSM position statement on cardiovascular preparticipation screening in athletes : Current evidence, knowledge gaps, recommendations and future directions. / Drezner, Jonathan A.; O'Connor, Francis G.; Harmon, Kimberly G.; Fields, Karl B.; Asplund, Chad A.; Asif, Irfan M.; Price, David E.; Dimeff, Robert J.; Bernhardt, David T.; Roberts, William O.

In: British Journal of Sports Medicine, Vol. 51, No. 3, 01.02.2017, p. 153-167.

Research output: Contribution to journalArticle

Drezner, JA, O'Connor, FG, Harmon, KG, Fields, KB, Asplund, CA, Asif, IM, Price, DE, Dimeff, RJ, Bernhardt, DT & Roberts, WO 2017, 'AMSSM position statement on cardiovascular preparticipation screening in athletes: Current evidence, knowledge gaps, recommendations and future directions' British Journal of Sports Medicine, vol. 51, no. 3, pp. 153-167. DOI: 10.1136/bjsports-2016-096781
Drezner, Jonathan A. ; O'Connor, Francis G. ; Harmon, Kimberly G. ; Fields, Karl B. ; Asplund, Chad A. ; Asif, Irfan M. ; Price, David E. ; Dimeff, Robert J. ; Bernhardt, David T. ; Roberts, William O./ AMSSM position statement on cardiovascular preparticipation screening in athletes : Current evidence, knowledge gaps, recommendations and future directions. In: British Journal of Sports Medicine. 2017 ; Vol. 51, No. 3. pp. 153-167
@article{6c64bea441ac4cb4a28a298c1268d5df,
title = "AMSSM position statement on cardiovascular preparticipation screening in athletes: Current evidence, knowledge gaps, recommendations and future directions",
abstract = "Cardiovascular screening in young athletes is widely recommended and routinely performed prior to participation in competitive sports. While there is general agreement that early detection of cardiac conditions at risk for sudden cardiac arrest and death (SCA/D) is an important objective, the optimal strategy for cardiovascular screening in athletes remains an issue of considerable debate. At the centre of the controversy is the addition of a resting ECG to the standard preparticipation evaluation using history and physical examination. The American Medical Society for Sports Medicine (AMSSM) formed a task force to address the current evidence and knowledge gaps regarding preparticipation cardiovascular screening in athletes from the perspective of a primary care sports medicine physician. The absence of definitive outcome-based evidence at this time precludes AMSSM from endorsing any single or universal cardiovascular screening strategy for all athletes, including legislative mandates. This statement presents a new paradigm to assist the individual physician in assessing the most appropriate cardiovascular screening strategy unique to their athlete population, community needs and resources. The decision to implement a cardiovascular screening programme, with or without the addition of ECG, necessitates careful consideration of the risk of SCA/D in the targeted population and the availability of cardiology resources and infrastructure. Importantly, it is the individual physician's assessment in the context of an emerging evidence base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm. AMSSM is committed to advancing evidenced-based research and educational initiatives that will validate and promote the most efficacious strategies to foster safe sport participation and reduce SCA/D in athletes.",
author = "Drezner, {Jonathan A.} and O'Connor, {Francis G.} and Harmon, {Kimberly G.} and Fields, {Karl B.} and Asplund, {Chad A.} and Asif, {Irfan M.} and Price, {David E.} and Dimeff, {Robert J.} and Bernhardt, {David T.} and Roberts, {William O.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1136/bjsports-2016-096781",
language = "English (US)",
volume = "51",
pages = "153--167",
journal = "British Journal of Sports Medicine",
issn = "0306-3674",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - AMSSM position statement on cardiovascular preparticipation screening in athletes

T2 - British Journal of Sports Medicine

AU - Drezner,Jonathan A.

AU - O'Connor,Francis G.

AU - Harmon,Kimberly G.

AU - Fields,Karl B.

AU - Asplund,Chad A.

AU - Asif,Irfan M.

AU - Price,David E.

AU - Dimeff,Robert J.

AU - Bernhardt,David T.

AU - Roberts,William O.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Cardiovascular screening in young athletes is widely recommended and routinely performed prior to participation in competitive sports. While there is general agreement that early detection of cardiac conditions at risk for sudden cardiac arrest and death (SCA/D) is an important objective, the optimal strategy for cardiovascular screening in athletes remains an issue of considerable debate. At the centre of the controversy is the addition of a resting ECG to the standard preparticipation evaluation using history and physical examination. The American Medical Society for Sports Medicine (AMSSM) formed a task force to address the current evidence and knowledge gaps regarding preparticipation cardiovascular screening in athletes from the perspective of a primary care sports medicine physician. The absence of definitive outcome-based evidence at this time precludes AMSSM from endorsing any single or universal cardiovascular screening strategy for all athletes, including legislative mandates. This statement presents a new paradigm to assist the individual physician in assessing the most appropriate cardiovascular screening strategy unique to their athlete population, community needs and resources. The decision to implement a cardiovascular screening programme, with or without the addition of ECG, necessitates careful consideration of the risk of SCA/D in the targeted population and the availability of cardiology resources and infrastructure. Importantly, it is the individual physician's assessment in the context of an emerging evidence base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm. AMSSM is committed to advancing evidenced-based research and educational initiatives that will validate and promote the most efficacious strategies to foster safe sport participation and reduce SCA/D in athletes.

AB - Cardiovascular screening in young athletes is widely recommended and routinely performed prior to participation in competitive sports. While there is general agreement that early detection of cardiac conditions at risk for sudden cardiac arrest and death (SCA/D) is an important objective, the optimal strategy for cardiovascular screening in athletes remains an issue of considerable debate. At the centre of the controversy is the addition of a resting ECG to the standard preparticipation evaluation using history and physical examination. The American Medical Society for Sports Medicine (AMSSM) formed a task force to address the current evidence and knowledge gaps regarding preparticipation cardiovascular screening in athletes from the perspective of a primary care sports medicine physician. The absence of definitive outcome-based evidence at this time precludes AMSSM from endorsing any single or universal cardiovascular screening strategy for all athletes, including legislative mandates. This statement presents a new paradigm to assist the individual physician in assessing the most appropriate cardiovascular screening strategy unique to their athlete population, community needs and resources. The decision to implement a cardiovascular screening programme, with or without the addition of ECG, necessitates careful consideration of the risk of SCA/D in the targeted population and the availability of cardiology resources and infrastructure. Importantly, it is the individual physician's assessment in the context of an emerging evidence base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm. AMSSM is committed to advancing evidenced-based research and educational initiatives that will validate and promote the most efficacious strategies to foster safe sport participation and reduce SCA/D in athletes.

UR - http://www.scopus.com/inward/record.url?scp=84988724961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988724961&partnerID=8YFLogxK

U2 - 10.1136/bjsports-2016-096781

DO - 10.1136/bjsports-2016-096781

M3 - Article

VL - 51

SP - 153

EP - 167

JO - British Journal of Sports Medicine

JF - British Journal of Sports Medicine

SN - 0306-3674

IS - 3

ER -